Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Champlin

Showing results (301-310 of 768) with videos related to

Pageof 77
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 17, 2009
Allogeneic stem cell transplantation for myelofibrosis with leukemic transformationStefan O Ciurea, Marcos de Lima, Sergio Giralt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2007
Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatmentBetul Oran, Michele Donato, Ana Aleman, et al.
Blood|February 15, 1993
Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia?O Ringdén, M M Horowitz, P Sondel, et al.
JCO Oncology Practice|January 13, 2026
Re-Evaluating Donor Selection Priorities for Hematopoietic Cell Transplantation With Post-Transplant CyclophosphamideRohtesh S Mehta, Yosra M Aljawai, Partow Kebriaei, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2000
Importance of radiation therapy for breast cancer patients treated with high-dose chemotherapy and stem cell transplantT A Buchholz, S L Tucker, R A Moore, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 18, 2025
Real-World Experience With Maribavir for Treatment of Refractory or Resistant Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients and Hematologic Malignancy PatientsMarilyne Daher, Fareed Khawaja, Amy Spallone, et al.
Lancet (London, England)|December 7, 1985
Bone-marrow transplantation for chronic myelogenous leukaemiaJ M Goldman, M M Bortin, R E Champlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2009
Rapid transport and infusion of hematopoietic cells is associated with improved outcome after myeloablative therapy and unrelated donor transplantHillard M Lazarus, Fangyu Kan, Sergey Tarima, et al.
Gene Therapy|April 1, 2011
The hyperactive Sleeping Beauty transposase SB100X improves the genetic modification of T cells to express a chimeric antigen receptorZ Jin, S Maiti, H Huls, et al.
Bone Marrow Transplantation|August 8, 2006
Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignanciesL Lekakis, S Giralt, D Couriel, et al.
Pageof 77

Showing results (301-310 of 768) with videos related to

Sort By:
Pageof 77
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 17, 2009
Allogeneic stem cell transplantation for myelofibrosis with leukemic transformationStefan O Ciurea, Marcos de Lima, Sergio Giralt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2007
Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatmentBetul Oran, Michele Donato, Ana Aleman, et al.
Blood|February 15, 1993
Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia?O Ringdén, M M Horowitz, P Sondel, et al.
JCO Oncology Practice|January 13, 2026
Re-Evaluating Donor Selection Priorities for Hematopoietic Cell Transplantation With Post-Transplant CyclophosphamideRohtesh S Mehta, Yosra M Aljawai, Partow Kebriaei, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2000
Importance of radiation therapy for breast cancer patients treated with high-dose chemotherapy and stem cell transplantT A Buchholz, S L Tucker, R A Moore, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 18, 2025
Real-World Experience With Maribavir for Treatment of Refractory or Resistant Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients and Hematologic Malignancy PatientsMarilyne Daher, Fareed Khawaja, Amy Spallone, et al.
Lancet (London, England)|December 7, 1985
Bone-marrow transplantation for chronic myelogenous leukaemiaJ M Goldman, M M Bortin, R E Champlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2009
Rapid transport and infusion of hematopoietic cells is associated with improved outcome after myeloablative therapy and unrelated donor transplantHillard M Lazarus, Fangyu Kan, Sergey Tarima, et al.
Gene Therapy|April 1, 2011
The hyperactive Sleeping Beauty transposase SB100X improves the genetic modification of T cells to express a chimeric antigen receptorZ Jin, S Maiti, H Huls, et al.
Bone Marrow Transplantation|August 8, 2006
Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignanciesL Lekakis, S Giralt, D Couriel, et al.
Pageof 77